![[Feedback]](/icons/banner/feedbackACT.gif){kind=icon}
![[For Subscribers]](/icons/banner/subscriberACT.gif){kind=icon}
![[Archive]](/icons/banner/archiveACT.gif){kind=icon}
![[Search]](/icons/banner/searchACT.gif){kind=icon}
![[Contents]](/icons/banner/tocACT.gif){kind=icon}
|
|
|
|
|
||
N Adham, P Romanienko, P Hartig, RL Weinshank and T Branchek
Neurogenetic Corporation, Paramus, New Jersey 07652.
The relationship between the serotonin 5-hydroxytryptamine1B (5-HT1B) and 5-HT1D receptors has been the topic of much investigation and speculation since their complementary species distribution was first appreciated. The cloning of genes encoding 5-HT1D receptors has provided tools to investigate this relationship directly. In this study, a rat gene has been cloned that encodes the rat 5-HT1B receptor. Evaluation of the structure of this gene shows that it is a member of the guanine nucleotide-binding protein-coupled receptor superfamily. Comparison of the amino acid sequence of the rat gene with the human 5- HT1D beta gene showed a 93% overall identity and a 96% identity in the transmembrane regions. Comparison of the two sequences revealed zero to two amino acid changes in each of these transmembrane regions, as well as a striking conservation in the connecting loops, indicative of the relationship expected for species homologues of the same gene. The rat gene was expressed transiently in COS-7 cells, and membranes derived from these cells were shown to bind [125I]iodocyanopindolol. The pharmacological profile of this binding site closely matched that of the native rat 5-HT1B receptor (r = 0.95) but not the 5-HT1D receptor (r = 0.07). The cloned rat 5-HT1B receptor was found to couple to the inhibition of adenylate cyclase activity, as expected for a 5-HT1B receptor. These data indicate that, although the 5-HT1B and 5-HT1D receptors are pharmacologically distinct, they are species variants of the same receptor gene, the 5-HT1D beta gene.
This article has been cited by other articles:
|
|
 |
|
  K. A. Berg, K. L. J. Evans, J. D. Cropper, and W. P. Clarke Temporal Regulation of Agonist Efficacy at 5-Hydroxytryptamine (5-HT)1A and 5-HT1B Receptors J. Pharmacol. Exp. Ther., January 1, 2003; 304(1): 200 - 205. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. Morikawa, O. J. Manzoni, J. C. Crabbe, and J. T. Williams Regulation of Central Synaptic Transmission by 5-HT1B Auto- and Heteroreceptors Mol. Pharmacol., April 13, 2001; 58(6): 1271 - 1278. [Abstract] [Full Text]
|
|
|
|
|
|
H. S. Hain, J. K. Belknap, and J. S. Mogil Pharmacogenetic Evidence for the Involvement of 5-Hydroxytryptamine (Serotonin)-1B Receptors in the Mediation of Morphine Antinociceptive Sensitivity J. Pharmacol. Exp. Ther., November 1, 1999; 291(2): 444 - 449. [Abstract] [Full Text]
|
|
|
|
 |
|
 G. Pineyro and P. Blier Autoregulation of Serotonin Neurons: Role in Antidepressant Drug Action Pharmacol. Rev., September 1, 1999; 51(3): 533 - 591. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. Bonaventure, L. Umans, M. H. M. Bakker, P. Cras, X. Langlois, W. H. M. L. Luyten, A. A. H. P. Megens, L. Serneels, F. Van Leuven, and J. E. Leysen Humanization of Mouse 5-Hydroxytryptamine1B Receptor Gene by Homologous Recombination: In Vitro and In Vivo Characterization Mol. Pharmacol., July 1, 1999; 56(1): 54 - 67. [Abstract] [Full Text]
|
|
|
|
 |
|
 S. D. Kahl, F. R. Hubbard, G. S. Sittampalam, and J. M. Zock Validation of a High Throughput Scintillation Proximity Assay for 5-HydroxytryptaminelE Receptor Binding Activity J Biomol Screen, February 1, 1997; 2(1): 33 - 40. [Abstract] [PDF]
|
|
|
|
 |
|
 J.-C. Rousselle, O. Massot, M. Delepierre, E. Zifa, B. Rousseau, and G. Fillion Isolation and Characterization of an Endogenous Peptide from Rat Brain Interacting Specifically with the Serotonergic 1B Receptor Subtypes J. Biol. Chem., January 12, 1996; 271(2): 726 - 735. [Abstract] [Full Text] [PDF]
|
|
 |
 |
 |
|
 |
 |
 |
